Inventor · disambiguated record
Limin Shang
Also filed as: SHANG LIMIN
9 granted patents·7 pending applications·287 citations·filing 2012–2024
87Inventor score
Files withNOVIMMUNE SA10MACDONALD DETTWILER & ASSOCIATES INC3MACDONALD DETTWILER & ASSOCIATES2SHANGHAI CLOBOTICS TECH CO LTD1
Top patents by PatentIndex Score
16 records- 0192US11969751B2System and method for automated artificial vision guided dispensing viscous fluids for caulking and sealing operationsMACDONALD DETTWILER & ASSOCIATES INC·Filed 2021·Granted Apr 30, 2024·2 cites·17 claims
- 0291US8693730B2Method of real-time tracking of moving/flexible surfacesMACDONALD DETTWILER & ASSOCIATES·Filed 2012·Granted Apr 8, 2014·257 cites·21 claims
- 0389US12448444B2Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereofNOVIMMUNE SA·Filed 2022·Granted Oct 21, 2025·2 cites·35 claims
- 0488US11192137B2System and method for automated artificial vision guided dispensing viscous fluids for caulking and sealing operationsMACDONALD DETTWILER & ASSOCIATES INC·Filed 2017·Granted Dec 7, 2021·10 cites·29 claims
- 0578US10689441B2Anti—TLR4 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2014·Granted Jun 23, 2020·4 cites·19 claims
- 0675US10556960B2Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkersNOVIMMUNE SA·Filed 2017·Granted Feb 11, 2020·2 cites·18 claims
- 0772US9101267B2Method of real-time tracking of moving/flexible surfacesMACDONALD DETTWILER & ASSOCIATES·Filed 2014·Granted Aug 11, 2015·7 cites·11 claims
- 0868US9688769B2Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkersNOVIMMUNE SA·Filed 2014·Granted Jun 27, 2017·2 cites·18 claims
- 0965US10776947B2Method, system and equipment for automatically detecting and tracking bladeSHANGHAI CLOBOTICS TECH CO LTD·Filed 2018·Granted Sep 15, 2020·1 cites·20 claims
- 1063US2024254223A1Reciprocally masked antibody-cytokine fusion proteins and methods of use thereofNOVIMMUNE SA·Filed 2023·Application pending·0 cites
- 1161US2025075000A1Combination therapy with a cea x cd28 bispecific antibody and blocking anti-pd-1 antibodies for enhanced in vivo anti-tumor activityNOVIMMUNE SA·Filed 2024·Application pending·0 cites
- 1260US2023295348A1Composition and methods for the selective activation of cytokine signaling pathwaysNOVIMMUNE SA·Filed 2023·Application pending·0 cites
- 1360US2024254234A1PD-L1xCD28 BISPECIFIC ANTIBODIES FOR IMMUNE CHECKPOINT-DEPENDENT T CELL ACTIVATIONNOVIMMUNE SA·Filed 2023·Application pending·0 cites
- 1456US2024002544A1Cd28 bispecific antibodies for targeted t cell activationNOVIMMUNE SA·Filed 2023·Application pending·0 cites
- 1556US2022080454A1System and method for automated artificial vision guided dispensing viscous fluids for caulking and sealing operationsMACDONALD DETTWILER & ASSOCIATES INC·Filed 2021·Application pending·0 cites
- 1633US2017038381A1Methods and compositions for identifying patient populations for diagnosis and treatment of tlr4-dependent disordersNOVIMMUNE SA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Limin Shang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →